<DOC>
	<DOCNO>NCT02909270</DOCNO>
	<brief_summary>A randomized , single-blind , multi-center , Phase III clinical trial evaluate efficacy safety adhesion barrier Mediclore versus treatment patient total thyroidectomy</brief_summary>
	<brief_title>Clinical Trail Evaluate Efficacy Safety Adhesion Barrier Mediclore Versus Treatment Patients With Total Thyroidectomy</brief_title>
	<detailed_description />
	<criteria>Written inform consent Male female least 20 year age Patients without clinically significant lab Patients schedule thyroidectomy Another clinical trial within 1 month History previous surgery position Anticoagulant , general steroid within week surgery Immunosuppression autoimmune disease General local infection Serious disease ( heart failure , renal failure , liver failure , uncontrolled hypertentsion , diabetes mellitus , coagulation deficiency ) Incompatible medication History drug alcohol abuse , mental disorder Pregnant lactate woman fertile woman use proper contraceptive method History esophagus diseases Keloid symptom</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>